Skip to main content

EGFR

Epidermal growth factor receptor (EGFR).

Other Topics:

ATM

(2)
BRCA

(2)
Breast Cancer

(3)
cancer care affiliate networks

(1)
cardiovascular

(1)
CDK12

(2)
clinical trial recruitment

(1)
CoC

(1)
dermatology

(1)
EGFR

(8)
endocrinology

(1)
Exon 19 Deletion

(4)
Gastric Cancer

(3)
gastroenterology

(1)
hepatology

(1)
high grade glioma

(3)
immunotherapy

(9)
irAE

(9)
KIT Exon 11

(2)
Lung Cancer

(11)
neurology

(1)
NSCLC

(9)
Ovarian Cancer

(4)
Prostate Cancer

(2)
pulmonology

(1)

Lung Cancer Patient with 3 EGFR Mutations

Topics — EGFR, Lung Cancer

Apr 1, 2021 | Education

Ovarian and Lung Cancer Patients with BRCA Reversion and Three EGFR Mutations

Topics — BRCA, EGFR, Lung Cancer, Ovarian Cancer

Apr 1, 2021 | Education

NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients

Topics — EGFR, Exon 19 Deletion, Lung Cancer, NSCLC

Mar 1, 2021 | Education

Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result

Topics — EGFR, Exon 19 Deletion, Lung Cancer

Mar 1, 2021 | Education

NSCLC Patient and Adjuvant Chemotherapy

Topics — EGFR, Lung Cancer, NSCLC

Mar 1, 2021 | Education

Patient with NSCLC Who Recurred within a Year

Topics — EGFR, Lung Cancer, NSCLC

Feb 1, 2021 | Education

Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion

Topics — EGFR, Exon 19 Deletion, Lung Cancer, NSCLC

Feb 1, 2021 | Education

Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy

Topics — EGFR, Exon 19 Deletion, Lung Cancer, NSCLC

Feb 1, 2021 | Education